Carolinas Wealth Consulting’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,907
| Closed | -$1.66M | – | 4 |
|
|
2025
Q1 | $1.66M | Sell |
7,907
-2,436
| -24% | -$510K | 0.36% | 44 |
|
|
2024
Q4 | $1.84M | Sell |
10,343
-365
| -3% | -$64.9K | 0.36% | 45 |
|
|
2024
Q3 | $2.11M | Buy |
10,708
+461
| +4% | +$91K | 0.38% | 41 |
|
|
2024
Q2 | $1.76M | Buy |
10,247
+2,189
| +27% | +$375K | 0.34% | 45 |
|
|
2024
Q1 | $1.47M | Sell |
8,058
-15,488
| -66% | -$2.82M | 0.29% | 50 |
|
|
2023
Q4 | $1.27M | Buy |
23,546
+152
| +0.6% | +$8.23K | 0.28% | 50 |
|
|
2023
Q3 | $1.14M | Buy |
23,394
+125
| +0.5% | +$6.1K | 0.28% | 50 |
|
|
2023
Q2 | $1.07M | Sell |
23,269
-650
| -3% | -$30K | 0.21% | 68 |
|
|
2023
Q1 | $1.37M | Buy |
23,919
+388
| +2% | +$22.2K | 0.29% | 55 |
|
|
2022
Q4 | $1.33M | Buy |
23,531
+3,196
| +16% | +$180K | 0.3% | 55 |
|
|
2022
Q3 | $675K | Sell |
20,335
-291
| -1% | -$9.66K | 0.17% | 68 |
|
|
2022
Q2 | $812K | Buy |
20,626
+15,086
| +272% | +$594K | 0.2% | 62 |
|
|
2022
Q1 | $898K | Buy |
5,540
+144
| +3% | +$23.3K | 0.2% | 62 |
|
|
2021
Q4 | $731K | Buy |
5,396
+577
| +12% | +$78.2K | 0.16% | 71 |
|
|
2021
Q3 | $520K | Sell |
4,819
-1,052
| -18% | -$114K | 0.12% | 83 |
|
|
2021
Q2 | $661K | Buy |
5,871
+743
| +14% | +$83.7K | 0.15% | 73 |
|
|
2021
Q1 | $555K | Buy |
5,128
+531
| +12% | +$57.5K | 0.14% | 76 |
|
|
2020
Q4 | $493K | Buy |
4,597
+838
| +22% | +$89.9K | 0.13% | 82 |
|
|
2020
Q3 | $329K | Buy |
3,759
+423
| +13% | +$37K | 0.11% | 84 |
|
|
2020
Q2 | $328K | Buy |
3,336
+11
| +0.3% | +$1.08K | 0.13% | 74 |
|
|
2020
Q1 | $253K | Buy |
+3,325
| New | +$253K | 0.14% | 81 |
|